Evaxion Biotech AS EVAX Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	22.03M	20.49M	16.75M	11.94M	86.93M	22.65M	15.23M	15.19M
Total Current Assets	16.99M	10.24M	7.12M	2.61M	56.31M	11.73M	10.7M	4.58M
Cash and Equivalents	13.18M	10.24M	7.12M	2.61M	37.65M	11.73M	7.99M	4.58M
Total Non-Current Assets	9.72M	10.25M	9.64M	9.34M	59.91M	10.92M	8.43M	10.61M
Total Liabilities	13.72M	13.91M	14.22M	14.68M	118.82M	20.05M	13.98M	15.11M
Total Current Liabilities	3.76M	0	0	0	47.77M	0	3.82M	0
Total Non-Current Liabilities	19.78M	13.91M	14.22M	14.68M	141.1M	20.05M	20.17M	15.11M
Common Equity	3.89M	4.22M	4.39M	4.42M	37.9M	7.96M	8.24M	8.73M
Retained Earnings	-72.66M	-78.72M	-84.26M	-89.76M	-721.6M	-112.03M	-112.97M	-114.9M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	11.08M	11.97M	40.16M	22.03M	86.93M
Total Current Assets	10.96M	10.95M	34.71M	16.99M	56.31M
Cash and Equivalents	9.56M	5.83M	32.17M	13.18M	37.65M
Total Non-Current Assets	9.36M	7.04M	32.44M	8.3M	-31.89M
Total Liabilities	1.72M	4.93M	7.73M	13.72M	118.82M
Total Current Liabilities	1.72M	4.93M	4.32M	3.76M	47.77M
Total Non-Current Liabilities	0	0	6.65M	19.78M	141.1M
Total Equity	9.36M	7.04M	32.44M	8.3M	-31.89M
Common Equity	2.48M	2.65M	3.76M	3.89M	37.9M
Retained Earnings	-15.81M	-27.28M	-50.43M	-72.66M	-721.6M